Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 10,369-10,380 of 10,592

Other study type icon

CompletedNCT01111149

Varenicline and Smoking Cessation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaOtherFrom 18 Years to 75 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Schizophrenia

Drug study icon

CompletedNCT00548470

Varenicline Effects In Schizophrenic Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Addiction, SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Addiction, Schizophrenia

Drug study icon

CompletedNCT01710137

Varenicline for Addiction Among Those With HIV/AIDS

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

CompletedNCT01509547

Varenicline for Adolescent Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 14 Years to 21 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Drug study icon

CompletedNCT00802919

Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, China, Israel
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Schizophrenia

Drug study icon

CompletedNCT01639560

Varenicline for Light Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Addiction

Drug study icon

CompletedNCT05367492

Varenicline for Nicotine Vaping Cessation in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 16 Years to 25 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Addiction

Drug study icon

TerminatedNCT04602494

Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 25 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Addiction

Drug study icon

WithdrawnNCT05294263

Varenicline for Cannabis and Tobacco Use Disorders in Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Addiction

Drug study icon

CompletedNCT00813800

Varenicline in Bipolar Depressed Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Mark Frye
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00790569

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 120 Years

Countries: United States
Sponsor: Butler Hospital
Condition: Addiction

Drug study icon

CompletedNCT01771627

Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Roswell Park Cancer Institute
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.